361 Capital’s Innospec IOSP Stock Holding History

361 Capital’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,523	Closed	-$1.29M	–	336
2019 Q4	$1.29M	Buy	+12,523	New	+$1.2M	0.36%	121
2019 Q1	–	Sell	-37,545	Closed	-$2.32M	–	362
2018 Q4	$2.32M	Buy	+37,545	New	+$2.58M	0.47%	83

Other funds holding IOSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

361 Capital's IOSP Position: Q1 2020 in Review

361 Capital sold out of Innospec (IOSP) in Q1 2020, closing a stake of 12,523 shares — an estimated $1.29M sold.

361 Capital first reported a position in IOSP in Q4 2018 and held it in 2 quarters. The position peaked at $2.32M in Q4 2018. 180 funds tracked by Wall St. Rank hold IOSP as of Q1 2020.

361 Capital reported no remaining Innospec position as of Q1 2020 after selling out during the quarter.
361 Capital sold 12,523 Innospec shares in Q1 2020, an estimated $1.29M.
361 Capital first reported a position in Innospec in Q4 2018 and held it in 2 quarters.
361 Capital's Innospec position peaked at $2.32M in Q4 2018.
180 funds tracked by Wall St. Rank held Innospec as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.